Antifungal use in hospitalized adults in U.S. academic health centers-Reference-Cited by-同舟云学术

Antifungal use in hospitalized adults in U.S. academic health centers

Published:2011-03-01 Issue:5 Volume:68 Page:415-418
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Pakyz Amy L.¹,Gurgle Holly E.²,Oinonen Michael J.³

Affiliation:

1. School of Pharmacy, Virginia Commonwealth University, Richmond.

2. University of Washington Medical Center, Seattle.

3. CDB/RM Operations, Comparative Data and Informatics, University HealthSystem Consortium, Oak Brook, IL

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/68/5/415/28349099/ajhp0415.pdf

Reference10 articles.

1. Trends in antibacterial use in US academic health centers;Pakyz;Arch Intern Med,2008

2. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004;National Nosocomial Infections Surveillance System;Am J Infect Control,2004

3. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry;Horn;Clin Infect Dis,2009

4. Pediatric antifungal utilization new drugs, new trends;Prasad;Pediatr Infect Dis J,2008

5. Antifungal use in intensive care units;Meyer;J Antimicrob Chemother,2007

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Analysis of the Use of Systemic Antifungals (Fluconazole, Itraconazole, and Terbinafine) in Galicia, Spain, between 2019 and 2022;Diseases;2024-01-12

2. In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years;Diagnostic Microbiology and Infectious Disease;2021-11

3. In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017–2018;Diagnostic Microbiology and Infectious Disease;2020-05

4. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018);Antimicrobial Agents and Chemotherapy;2020-03-24

5. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016;Open Forum Infectious Diseases;2019-03